Literature DB >> 19898786

[Perioperative thromboprophylaxis in adults].

Sabine Eichinger1.   

Abstract

According to the concept of Virchow, alterations of the blood flow, vascular injury and hypercoagulability of the blood (due to inherited or acquired thrombophilia or as a consequence of perioperative coagulation activation) are causally related to the risk of venous thrombosis. The overall risk of venous thromboembolic events in the perioperative setting ranges between <10% and >50%. The risk is highest in patients undergoing major orthopaedic surgery or cancer surgery. The aim of perioperative thrombosis prophylaxis is to reduce perioperative morbidity and mortality. The article discusses patient- and intervention-dependent thromboprophylactic measures. Recent recommendations for non-pharmacological and pharmacological prophylaxis are presented including the information on the beginning and duration of anticoagulation. Management strategies for patients undergoing abdominal and orthopaedic surgery as well as special aspects of the neurosurgical population and of cancer surgery are highlighted.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19898786     DOI: 10.1007/s10354-009-0711-7

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  44 in total

1.  The treatment of venous thromboembolic disorders: new challenges and opportunities.

Authors:  Paolo Prandoni
Journal:  Haematologica       Date:  2003-06       Impact factor: 9.941

2.  A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project.

Authors:  Giancarlo Agnelli; Giorgio Bolis; Lorenzo Capussotti; Roberto Mario Scarpa; Francesco Tonelli; Erminio Bonizzoni; Marco Moia; Fabio Parazzini; Romina Rossi; Francesco Sonaglia; Bettina Valarani; Carlo Bianchini; Gualberto Gussoni
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

3.  Is Virchow's triad complete?

Authors:  Paul A Kyrle; Sabine Eichinger
Journal:  Blood       Date:  2009-08-06       Impact factor: 22.113

4.  Antithrombotic prophylaxis in patients undergoing laparoscopic cholecystectomy.

Authors:  H Bounameaux; D Didier; O Polat; S Desmarais; P de Moerloose; O Huber
Journal:  Thromb Res       Date:  1997-05-01       Impact factor: 3.944

Review 5.  Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.

Authors:  R D Hull; G F Pineo; P D Stein; A F Mah; S M MacIsaac; O E Dahl; M Butcher; R F Brant; W A Ghali; D Bergqvist; G E Raskob
Journal:  Ann Intern Med       Date:  2001-11-20       Impact factor: 25.391

6.  The incidence of deep venous thrombosis after arthroscopic knee surgery.

Authors:  J W Jaureguito; A E Greenwald; J F Wilcox; L E Paulos; T D Rosenberg
Journal:  Am J Sports Med       Date:  1999 Nov-Dec       Impact factor: 6.202

7.  Flexibility in administration of fondaparinux for prevention of symptomatic venous thromboembolism in orthopaedic surgery.

Authors:  Clifford W Colwell; Lewis M Kwong; Alexander G G Turpie; Bruce L Davidson
Journal:  J Arthroplasty       Date:  2006-01       Impact factor: 4.757

8.  Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (reviparin): Results of a randomized controlled trial.

Authors:  T Wirth; B Schneider; F Misselwitz; M Lomb; H Tüylü; R Egbring; P Griss
Journal:  Arthroscopy       Date:  2001-04       Impact factor: 4.772

Review 9.  Preventing thromboembolic complications in cancer patients after surgery: a role for prolonged thromboprophylaxis.

Authors:  Morten S Rasmussen
Journal:  Cancer Treat Rev       Date:  2002-06       Impact factor: 12.111

10.  Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty.

Authors:  R H White; P S Romano; H Zhou; J Rodrigo; W Bargar
Journal:  Arch Intern Med       Date:  1998-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.